Defining the clinical course of multiple sclerosis: Results of an international survey

Neurology

Volumn 46, Issue 4, 1996, Pages 907-911

  Lublin, Fred D ^a   Reingold, Stephen C ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b National Multiple Sclerosis Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; NOMENCLATURE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REVIEW; SAFETY;

EID: 0029913882     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.4.907     Document Type: Review

References (20)

1. Matthews WB, Compston A, Allen IV, Martyn CN, eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991.
2. Poser S. Multiple sclerosis: an analysis of 812 cases by means of electronic data processing. Berlin: Springer, 1978.
3. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
4. Phadke JG. Survival patterns and cause of death in patients with multiple sclerosis: results from an epidemiological survey in northeast Scotland. J Neuro Neurosurg Psychiatry 1987;50: 523-531.
5. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
6. Verjans E, Theys P, Delmotte P, Carton H. Clinical parameters and intrathecal IgG synthesis as prognostic factors in multiple sclerosis. Part I. J Neurol 1983;229:155-165.
7. Confavreux C, Compston DAS, Hommes OR, et al. EDMUS, a European database for multiple sclerosis. J Neuro Neurosurg Psychiatry 1992;55:671-676.
8. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, placebo-controlled trial. Neurology 1993;43:655-661.
9. Jacobs LD, Cookfair DL, Rudick RA, et al. Results of a phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis [abstract]. Ann Neurol 1994; 36:259.
10. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer I reduces the relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multi-center, double-blind, placebo-controlled trial. Neurology 1995;45: 1268-1276.
11. Alter M, Byrne TN, Daube JR, et al. Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994;44: 1537-1540.
12. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1995;1:37-47.
13. Kurtzke JF, Beebe GW, Nagler B, et al. Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness. J Chronic Dis 1977;30:819-830.
14. Thompson AJ, Hutchinson M, Brazil J, et al. A clinical and laboratory study of benign multiple sclerosis. Q J Med 1986; 58:69-80.
15. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
16. Isaac C, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38: 1511-1515.
17. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-929.
18. Koopmans RA, Li DKB, Oger JJF, et al. Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months. Ann Neurol 1989;26:248-256.
19. Willoughby EW, Grochowski E, Li DKB, et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-49.
20. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-568.